Pharmacology (Advanced): Antimicrobials, Oncology, Antidotes, Adverse Effects & Cytochrome P450 Interactions
Advanced antimicrobial mechanisms and resistance, cancer chemotherapy, targeted biologics, toxicology antidotes, classic drug adverse reactions, and cytochrome P450 pharmacology.
- Level
- advanced
- Languages
- en → en
- Cards
- 32
- Markdown
- Pharmacology (Advanced): Antimicrobials, Oncology, Antidotes, Adverse Effects & Cytochrome P450 Interactions (.md)
Flashcards (32)
| # | Front (Term / Question) | Back (Definition / Answer) | Example | Multiple-Choice Options |
|---|---|---|---|---|
| 1 | How do Polyene antifungals (Amphotericin B, Nystatin) and Azole antifungals (Fluconazole, Voriconazole) differ in their targeting of fungal ergosterol? | Polyenes (Amphotericin B, Nystatin) bind directly to pre-existing Ergosterol in the fungal cell membrane, forming transmembrane pore-like ion channels that leak intracellular K+ and Mg2+, killing the cell. Azoles inhibit the fungal cytochrome P450 enzyme 14-alpha-demethylase, blocking the conversion of Lanosterol to Ergosterol, impairing fungal cell membrane synthesis. | ||
| 2 | What are the immune checkpoint targets of Pembrolizumab and Ipilimumab, and how are immune-related adverse events (irAEs) managed? | Pembrolizumab (and Nivolumab) blocks Programmed Cell Death Protein 1 (PD-1), and Ipilimumab blocks Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4). By blocking these inhibitory checkpoint receptors on T-cells, they restore antitumor T-cell cytotoxicity. Immune-related adverse events (autoimmune colitis, pneumonitis, hypophysitis, hepatitis, dermatitis) are managed by interrupting checkpoint therapy and initiating high-dose systemic Corticosteroids (e.g., Prednisone 1-2 mg/kg/day). | ||
| 3 | What specific chelating agents are indicated for Lead, Iron, and Copper toxicities? | Lead poisoning: Dimercaprol (BAL) + Calcium Disodium EDTA for severe toxicity; oral Succimer (DMSA) for pediatric outpatient chelation. Acute Iron poisoning: Deferoxamine (IV iron chelator; forms ferrioxamine complex producing 'vin rosé' reddish urine). Copper overload (Wilson's disease): Penicillamine or Trientine (chelators promoting urinary copper excretion) combined with oral Zinc (blocks intestinal copper absorption). | ||
| 4 | How do Macrolides and Tetracyclines differ in their ribosomal subunit binding, and why are tetracyclines contraindicated in young children and pregnancy? | Macrolides (Azithromycin, Clarithromycin) bind the 50S ribosomal subunit, blocking the exit tunnel and peptide chain elongation. Tetracyclines (Doxycycline, Minocycline) reversibly bind the 30S ribosomal subunit, preventing attachment of aminoacyl-tRNA. Tetracyclines chelate divalent cations (Ca2+), accumulating in growing teeth and bones, leading to permanent enamel discoloration (yellow/brown teeth) and reversible bone growth retardation in children under 8 years and during pregnancy. | ||
| 5 | What happens to the International Normalized Ratio (INR) when a patient stabilized on Warfarin starts Co-trimoxazole (Bactrim) or Metronidazole? | Bactrim (TMP-SMX) and Metronidazole are potent stereoselective inhibitors of Cytochrome P450 2C9 (CYP2C9), the primary hepatic enzyme responsible for metabolizing the more potent S-enantiomer of Warfarin. Inhibiting CYP2C9 markedly slows warfarin clearance, leading to supratherapeutic INR elevation and life-threatening spontaneous hemorrhage unless the warfarin dose is empirically reduced by 30-50%. | ||
| 6 | How do Vinca alkaloids (Vincristine, Vinblastine) and Taxanes (Paclitaxel) differ in their mechanisms of microtubule inhibition? | Vinca alkaloids (Vincristine, Vinblastine) bind beta-tubulin and INHIBIT tubulin polymerization, preventing mitotic spindle assembly and arresting cells in metaphase (vincristine causes dose-limiting peripheral neurotoxicity). Taxanes (Paclitaxel, Docetaxel) bind beta-tubulin and PREVENT microtubule DEPOLYMERIZATION, hyper-stabilizing the mitotic spindle so chromosomes cannot segregate. | ||
| 7 | What is the biochemical target of Echinocandin antifungals (Caspofungin, Micafungin), and what is their primary clinical role? | Non-competitively inhibit the synthesis of Beta-(1,3)-D-glucan, an essential cross-linking structural polysaccharide in the fungal cell wall (analogous to beta-lactams in bacteria). First-line intravenous therapy for invasive Candidiasis, candidemia, and salvage therapy for invasive Aspergillosis. | ||
| 8 | What culprit drugs cause Drug-Induced Lupus Erythematosus (DILE), and what autoantibody is positive in >95% of cases? | Classic culprit drugs (mnemonic: 'SHIPP'): Sulfasalazine, Hydralazine, Isoniazid, Procainamide, and Penicillamine (with Hydralazine and Procainamide having the highest incidence, especially in slow hepatic acetylators). Characterized by fever, arthralgias, and serositis. Greater than 95% of DILE cases test positive for Anti-Histone Antibodies, whereas Anti-dsDNA antibodies (hallmark of systemic lupus) are typically negative. | ||
| 9 | What viral enzyme is required to activate Acyclovir, and what is the essential preventive measure against intravenous acyclovir nephrotoxicity? | Requires monophosphorylation by Herpesvirus-specific Thymidine Kinase (converting acyclovir to acyclovir monophosphate; host cellular kinases then convert it to acyclovir triphosphate, which inhibits viral DNA polymerase). Intravenous acyclovir can precipitate as insoluble needle-shaped crystals in renal collecting ducts, causing acute crystal nephropathy; this is prevented by aggressive IV volume hydration and slow drug infusion over 1-2 hours. | ||
| 10 | What is the molecular target of beta-lactam antibiotics, and how do beta-lactamase inhibitors overcome bacterial enzymatic resistance? | Beta-lactams (penicillins, cephalosporins, carbapenems) are structural analogs of D-Ala-D-Ala that covalently bind and inhibit Transpeptidases (Penicillin-Binding Proteins / PBPs), blocking peptidoglycan cell wall cross-linking and triggering autolysin-mediated bacterial lysis. Beta-lactamase inhibitors (Clavulanate, Sulbactam, Tazobactam, Avibactam) are suicide inhibitors that irreversibly bind bacterial beta-lactamase enzymes, protecting the co-administered beta-lactam. | ||
| 11 | What is the mechanism of action of Vancomycin, and what is the pathophysiologic mechanism of 'Vancomycin Flushing Syndrome' (Red Man Syndrome)? | Vancomycin binds directly to the D-alanyl-D-alanine terminus of cell wall peptidoglycan precursors, sterically blocking transpeptidation and transglycosylation in Gram-positive bacteria. Flushing syndrome is an infusion-related adverse reaction caused by DIRECT non-IgE-mediated degranulation of mast cells and basophils releasing histamine, triggered by rapid infusion rates; it is prevented or treated by slowing the infusion rate (<= 1000 mg/hr) and pre-treating with antihistamines. | ||
| 12 | How do Protamine Sulfate and Vitamin K1 / 4-Factor PCC differ in reversing Unfractionated Heparin versus Warfarin anticoagulation? | Unfractionated Heparin reversal: Protamine Sulfate is a strongly basic, positively charged polycationic peptide that binds stoichiometrically to strongly acidic, negatively charged heparin molecules, forming a stable inactive salt. Warfarin reversal: Intravenous Vitamin K1 (Phytonadione) stimulates de novo hepatic synthesis of functional clotting factors II, VII, IX, and X (takes 6-24 hours); immediate emergency reversal is achieved with 4-Factor Prothrombin Complex Concentrate (4F-PCC) containing active vitamin K-dependent factors. | ||
| 13 | What medications are high-risk culprits for Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), and what pharmacogenomic screening is recommended for Carbamazepine? | High-risk drugs: Allopurinol, Anticonvulsants (Carbamazepine, Lamotrigine, Phenytoin, Phenobarbital), Sulfonamide antibiotics (TMP-SMX), and Nevirapine. Patients of Asian descent (Han Chinese, Thai, Filipino) must undergo pharmacogenomic screening for the HLA-B*1502 allele prior to starting Carbamazepine, as carrying this allele confers a massive relative risk for fatal SJS/TEN. | ||
| 14 | What is the molecular mechanism and dose-limiting organ toxicity of Cisplatin, and what chemoprotective scavenger is used? | Cisplatin is an inorganic platinum coordination complex that forms intra-strand and inter-strand cross-links at guanine N-7 positions in DNA, bending the helix and triggering apoptosis. Major dose-limiting toxicities: severe acute tubular necrosis (nephrotoxicity), high-frequency ototoxicity, and extreme emetogenicity. Chemoprotective agent: Amifostine (free radical scavenger) alongside aggressive chloride-containing isotonic saline hydration. | ||
| 15 | What is the specific pharmacologic antidote for toxic overdose of Beta-adrenergic blockers? | Intravenous Glucagon. Glucagon stimulates dedicated myocardial glucagon G-protein coupled receptors that directly activate Adenylyl Cyclase via Gs, BYPASSING the blocked beta-1 adrenergic receptors to generate cAMP, restoring cardiac intracellular calcium influx, inotropy, and heart rate. | ||
| 16 | What is the mechanism of action of Fomepizole in toxic alcohol (methanol and ethylene glycol) poisoning? | A potent competitive inhibitor of Alcohol Dehydrogenase (ADH). It prevents the metabolism of Ethylene Glycol into toxic glycolic and oxalic acids (which cause acute renal failure and calcium oxalate crystals) and Methanol into toxic formaldehyde and formic acid (which cause optic papillitis, retinal toxicity, and blindness). Ethanol can be used as an alternative competitive ADH substrate if fomepizole is unavailable. | ||
| 17 | What is the enzymatic mechanism of 5-Fluorouracil (5-FU), and how does Leucovorin alter its pharmacodynamic activity differently than with methotrexate? | 5-FU is metabolized to 5-fluoro-2'-deoxyuridine monophosphate (5-FdUMP), which forms a stable covalent ternary complex with Thymidylate Synthase and 5,10-methylenetetrahydrofolate, irreversibly inhibiting dTMP synthesis ('thymineless cell death'). Unlike in methotrexate therapy where leucovorin acts as a rescue agent, in 5-FU therapy Leucovorin is administered to ENHANCE and potentiate 5-FU cytotoxicity by stabilizing the inhibitory ternary complex. | ||
| 18 | What is the molecular target of Imatinib (Gleevec), and for which hematologic malignancy is it targeted therapy? | A small-molecule competitive inhibitor of the ATP-binding pocket of the BCR-ABL receptor tyrosine kinase, created by the Philadelphia chromosome t(9;22)(q34;q11) reciprocal translocation. First-line targeted therapy for Chronic Myeloid Leukemia (CML); also inhibits c-KIT (CD117) tyrosine kinase in Gastrointestinal Stromal Tumors (GIST). | ||
| 19 | What are the specific reversal agents (antidotes) for the Direct Oral Anticoagulants (DOACs) Dabigatran and Factor Xa inhibitors (Apixaban, Rivaroxaban)? | Dabigatran (direct oral thrombin / Factor IIa inhibitor) reversal: Idarucizumab (Praxbind), a humanized monoclonal antibody Fab fragment that binds dabigatran with 350-fold higher affinity than thrombin. Factor Xa inhibitors (Apixaban, Rivaroxaban, Edoxaban) reversal: Andexanet alfa (Andexxa), a recombinant catalytically inactive decoy Factor Xa protein that binds and sequesters Factor Xa inhibitors away from native Factor Xa. | ||
| 20 | What classic pharmacokinetic drugs act as potent Cytochrome P450 Enzyme Inducers (CRAP GPS mnemonic)? | C: Carbamazepine; R: Rifampin; A: Alcohol (chronic); P: Phenytoin; G: Griseofulvin; P: Phenobarbital; S: St. John's Wort. Induction of CYP enzymes increases metabolic clearance of co-administered substrate drugs (e.g., oral contraceptives, warfarin, antiretrovirals), dramatically REDUCING their plasma concentrations and clinical efficacy. | ||
| 21 | What is the clinical role of Cilastatin when formulated with Imipenem, and what central nervous system adverse effect is associated with carbapenems? | Imipenem is rapidly hydrolyzed and inactivated in the renal brush border by the brush-border enzyme Dehydropeptidase-I (producing nephrotoxic metabolites). Cilastatin is a competitive dehydropeptidase-I inhibitor that prevents renal degradation, maintaining high active imipenem urinary concentrations. Carbapenems (especially imipenem, particularly in patients with renal insufficiency or underlying brain lesions) lower the seizure threshold and can precipitate generalized Seizures. | ||
| 22 | What classic pharmacokinetic drugs act as potent Cytochrome P450 Enzyme Inhibitors (SICKFACES.COM mnemonic)? | S: Sodium valproate; I: Isoniazid; C: Cimetidine; K: Ketoconazole; F: Fluconazole; A: Alcohol (acute intoxication); C: Chloramphenicol; E: Erythromycin / Clarithromycin; S: Sulfonamides; C: Ciprofloxacin; O: Omeprazole; M: Metronidazole; plus Grapefruit juice. CYP inhibition decreases substrate metabolism, leading to elevated drug blood levels and acute drug toxicity. | ||
| 23 | What toxic metabolite produced by Cyclophosphamide causes hemorrhagic cystitis, and what uroprotective agent neutralizes it? | Cyclophosphamide (an alkylating mustard agent) is metabolized by hepatic CYP450 to 4-hydroxycyclophosphamide, which spontaneously breaks down into phosphoramide mustard (active alkylator) and Acrolein. Acrolein concentrates in the bladder and sloughs urothelium, producing sterile hemorrhagic cystitis. Preventive uroprotective agent: Mesna (sodium 2-mercaptoethanesulfonate), which binds and inactivates acrolein in the urinary tract, alongside vigorous IV hydration. | ||
| 24 | What is the mechanism of action of Linezolid, and what dangerous drug interaction can occur when combined with serotonergic medications? | Binds to the 23S ribosomal RNA of the 50S subunit, preventing formation of the functional 70S initiation complex; active against resistant Gram-positive pathogens (MRSA, VRE). Linezolid is a weak, reversible, non-selective Monoamine Oxidase Inhibitor (MAOI); co-administration with SSRIs, SNRIs, or other serotonergic drugs can precipitate life-threatening Serotonin Syndrome. | ||
| 25 | What are the clinical antidotes used in acute Carbon Monoxide poisoning and Cyanide poisoning? | Carbon monoxide: 100% normobaric oxygen via tight non-rebreather mask (shortens Hb-CO half-life from 300 to 90 min) or Hyperbaric Oxygen (HBO; shortens half-life to 20-30 min). Cyanide poisoning: Hydroxocobalamin (first-line, binds cyanide to form cyanocobalamin [vitamin B12] excreted in urine) OR the Cyanide Antidote Kit: Sodium Nitrite (induces methemoglobinemia which binds cyanide) followed by Sodium Thiosulfate (donates sulfur to rhodanese to convert cyanide to thiocyanate). | ||
| 26 | Which antimicrobial agents provide reliable bactericidal coverage against Pseudomonas aeruginosa? | Antipseudomonal penicillins: Piperacillin-tazobactam. Cephalosporins: Cefepime (4th gen), Ceftazidime (3rd gen). Carbapenems: Meropenem, Imipenem-cilastatin, Doripenem (NOT Ertapenem!). Fluoroquinolones: Ciprofloxacin, Levofloxacin. Aminoglycosides: Amikacin, Tobramycin, Gentamicin. Monobactam: Aztreonam. Polymyxins: Colistin, Polymyxin B. | ||
| 27 | What is the dose-limiting toxicity of Anthracyclines (Doxorubicin, Daunorubicin), and what iron-chelating cardioprotectant is utilized? | Dose-dependent dilated cardiomyopathy and congestive heart failure, mediated by the generation of iron-dependent free radicals (hydrogen peroxide and hydroxyl radicals) causing membrane lipid peroxidation and myofibrillar loss. The cardioprotective agent is Dexrazoxane, an intracellular iron-chelating agent that prevents free radical formation when high cumulative doses of doxorubicin are reached. | ||
| 28 | What are the molecular targets and clinical indications of Trastuzumab and Rituximab? | Trastuzumab: humanized monoclonal antibody against the extracellular domain of Human Epidermal Growth Factor Receptor 2 (HER2/neu / ERBB2); used in HER2-overexpressing breast and gastric cancers; adverse effect is reversible cardiotoxicity (decreased LVEF without anthracycline-like myofibrillar necrosis). Rituximab: chimeric monoclonal antibody against CD20 on B-lymphocytes; used in non-Hodgkin lymphomas, CLL, and severe autoimmune diseases. | ||
| 29 | What is the enzymatic target of Methotrexate, and what rescue agent is administered following high-dose methotrexate chemotherapy? | Competitively inhibits Dihydrofolate Reductase (DHFR), blocking conversion of dihydrofolate to tetrahydrofolate (THF), which depletes 1-carbon carriers needed for de novo purine synthesis and thymidylate (dTMP) synthesis. High-dose methotrexate rescue agent: Leucovorin (Folinic Acid / 5-formyl-THF), which bypasses DHFR to replenish intracellular folate pools in normal tissues. | ||
| 30 | What is the ribosomal target of Aminoglycosides (Gentamicin, Amikacin), and why are they clinically ineffective against obligate anaerobic bacteria? | Irreversibly bind the 30S ribosomal subunit, causing misreading of genetic code and inhibiting protein synthesis translocation. Transport across the bacterial inner cytoplasmic membrane requires an active, oxygen-dependent electron transport system; obligate anaerobes (e.g., Clostridium, Bacteroides) lack this oxygen-dependent uptake mechanism and are intrinsically resistant. Toxicities: Ototoxicity (vestibular/cochlear) and Nephrotoxicity (ATN). | ||
| 31 | What are the hallmarks of Neuroleptic Malignant Syndrome (NMS) versus Malignant Hyperthermia, and how do their pharmacologic treatments differ? | NMS: caused by central Dopamine D2 receptor blockade (antipsychotics); characterized by 'lead-pipe' muscle rigidity, hyperthermia, autonomic instability, and extreme CK elevation; treated with Bromocriptine (dopamine agonist) and Dantrolene. Malignant Hyperthermia: triggered by volatile anesthetics and succinylcholine via uncontrolled skeletal muscle ryanodine receptor (RYR1) calcium release; treated immediately with IV Dantrolene (RYR1 inhibitor) and active cooling. | ||
| 32 | What topoisomerase enzymes are inhibited by Fluoroquinolones (Ciprofloxacin, Levofloxacin), and what are their FDA Black Box Warnings? | Inhibit bacterial DNA Gyrase (Topoisomerase II) in Gram-negative bacteria and Topoisomerase IV in Gram-positive bacteria, inducing double-stranded DNA breaks. Black Box Warnings: 1) Tendinopathy and Tendon Rupture (most commonly Achilles tendon); 2) Peripheral neuropathy; 3) Central nervous system toxicities (seizures, psychosis); 4) Exacerbation of muscle weakness in Myasthenia Gravis; 5) Increased risk of Aortic Aneurysm dissection or rupture; 6) QTc prolongation. |